Core Insights - The event "Caring for Dialysis Patients" aims to shift the management of hyperphosphatemia in dialysis patients from passive to proactive, focusing on standardized treatment processes to improve patient outcomes [1][3]. Group 1: Hyperphosphatemia in Dialysis Patients - Hyperphosphatemia is a common and severe complication among dialysis patients, with a prevalence rate of 76% in China, while the phosphorus control rate is only 30%-40% [3]. - The innovative product, Vantive® (Tianapano hydrochloride), is the first and only approved phosphate absorption inhibitor, which significantly improves phosphorus control rates to over 70% and has the potential to alleviate constipation [3][4]. Group 2: Integrated Management and Patient-Centric Approach - The focus is on creating a comprehensive health solution for chronic kidney disease (CKD) management, emphasizing patient-centered care and integrated management strategies [4]. - Companies are exploring digital tools to provide long-term management support for patients, aiming to bridge the gap in standardized treatment [4][5]. Group 3: Modern Medical Management Philosophy - Modern kidney disease management emphasizes individualized treatment and patient experience, allowing healthcare providers to choose strategies that enhance efficacy while minimizing patient burden [5]. - Effective communication and long-term adherence are crucial for successful phosphorus management, with a focus on improving patients' quality of life alongside achieving treatment goals [5].